---
layout: post
title: January 2011 USANs
date: '2011-01-11T21:54:00.022Z'
author: John Overington
tags:
- INNS and USANS
modified_time: '2011-01-20T16:28:48.344Z'
thumbnail: http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s72-c/inns+and+usans.png
blogger_id: tag:blogger.com,1999:blog-2546008714740235720.post-8226427156706605759
blogger_orig_url: http://chembl.blogspot.com/2011/01/january-2011-usans-have-just-been.html
---

<center><br />
<a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s1600/inns+and+usans.png" imageanchor="1" style="margin-left: 1em; margin-right: 1em;"><img border="0" height="80" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TRMbPgzd6CI/AAAAAAAAA9Y/DWPPmKSu7jg/s320/inns+and+usans.png" width="320" /></a></center><center><br />
</center>The January 2011 USANs have been published, these are:<br />
<br />
<table border="1"><tbody>
<tr><td><b>USAN</b></td><td><b>Research code</b> </td><td><b>Structure</b></td><td><b>Drug Type</b> </td><td><b>Drug Class</b></td><td><b>Target</b> </td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/insulin-degludec.pdf">insulin-degludec</a></td><td>NN-1250</td><td><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TTA80pPakDI/AAAAAAAAA-0/sjFXp-yHDoU/s1600/insulin_degludec.png"><img tooltip="Insulin degludec nn-1250 GIVEQCCTSICSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPK" alt="Insulin degludec nn-1250 GIVEQCCTSICSLYQLENYCN FVNQHLCGSHLVEALYLVCGERGFFYTPK" border=0 src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TTA80pPakDI/AAAAAAAAA-0/sjFXp-yHDoU/s320/insulin_degludec.png" width="100" /></a></td><td>protein</td><td>therapeutic</td><td><a href="http://www.uniprot.org/uniprot/P06213">insulin receptor</a></td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/lesinurad.pdf">lesinurad</a></td><td>RDEA-594</td><td><a href="http://3.bp.blogspot.com/_SlPG9DIz_AA/TTA845a6hdI/AAAAAAAAA-4/uqiKPcMVG_g/s1600/lesinurad.png"><img tooltip="Lesinurad RDEA-594 FGQFOYHRJSUHMR-UHFFFAOYSA-N" alt="Lesinurad RDEA-594 FGQFOYHRJSUHMR-UHFFFAOYSA-N" border="0" src="http://3.bp.blogspot.com/_SlPG9DIz_AA/TTA845a6hdI/AAAAAAAAA-4/uqiKPcMVG_g/s1600/lesinurad.png" width="100" /></a></td><td>synthetic small molecule</td><td>therapeutic</td><td><a href="http://www.uniprot.org/uniprot/Q96S37">URAT1 transporter</a></td></tr>
<tr><td><a href="http://www.ama-assn.org/ama1/pub/upload/mm/365/vidupiprant.pdf">vidupiprant</a></td><td>AMG-853</td><td><a href="http://1.bp.blogspot.com/_SlPG9DIz_AA/TTA88nTKbZI/AAAAAAAAA-8/QpgINV0T2a8/s1600/vidupiprant.png"><img tooltip="AMG-853 Vidupiprant PFWVGKROPKKEDW-UHFFFAOYSA-N" alt="AMG-853 Vidupiprant PFWVGKROPKKEDW-UHFFFAOYSA-N" border="0" src="http://1.bp.blogspot.com/_SlPG9DIz_AA/TTA88nTKbZI/AAAAAAAAA-8/QpgINV0T2a8/s320/vidupiprant.png" width="100" /></a></td><td>synthetic small molecule</td><td>therapeutic</td><td><a href="http://www.uniprot.org/uniprot/Q9Y5Y4">CRTH2 receptor</a> and <a href="http://www.uniprot.org/uniprot/Q13258">D-prostanoid receptor</a></td></tr>
</tbody></table><br />
<br />
<table border="1"><tbody>
<tr><td><b>Drug Type</b></td><td><b>Number</b></td></tr>
<tr><td>synthetic small molecule</td><td>2</td></tr>
<tr><td>natural product derived small molecule</td><td>0</td></tr>
<tr><td>protein</td><td>1</td></tr>
<tr><td>monoclonal antibody</td><td>0</td></tr>
<tr><td>enzyme</td><td>0</td></tr>
<tr><td><b>Total for year</b></td><td><b>3</b></td></tr>
</tbody><tbody> </tbody></table><br />
<script type="text/javascript" src="https://www.ebi.ac.uk/chembldb/extra/js/jquery-1.3.2.min.js"></script><br />
<script type="text/javascript" src="https://www.ebi.ac.uk/chembldb/extra/js/jquery.qtip-1.0.0-rc3.min.js"></script><br />
<script type="text/javascript" src="https://www.ebi.ac.uk/chembldb/extra/js/chemblog.js"></script>